Muraro, Paolo A <br/><br/>
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance.  [electronic resource] 

 -  Neurology  05 2018 
 - 819-820 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/WNL.0000000000005409  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acalculous Cholecystitis<br/>Alemtuzumab<br/>Humans<br/>Iatrogenic Disease